Artrofoon

General characteristics. Structure:

Deystvubshchy substance: antibodies to a human factor of a necrosis of a tumor an alpha affinely cleared - 0,003 g.
Excipients: lactose, cellulose microcrystallic, magnesium stearate.

Tablets of a ploskotsilindrichesky form, with risky and a facet, from white till  almost white  color.  On  the flat  party  from  risky       MATERIA MEDICA text is put,   on  other  flat  party      ARTHROFON text is put.

Pharmacological properties:

Experimentally it is also clinically proved that drug the alpha (ФНОα) at a pseudorheumatism, an osteoarthrosis, osteochondrosis modulates development and functional activity of an internal cause of a necrosis of a tumor, dorsodynias. Has antiinflammatory and analgeziruyushchy effect. Due to reduction of products of a number of pro-inflammatory cytokines, mediators of an inflammation interferes with progressing of inflammatory defeat of fabrics and target organs at inflammatory and degenerative diseases.

Indications to use:

Pseudorheumatism, osteoarthrosis (including spondylarthrosis) and other diseases of joints; during remission use of drug as a part of monotherapy, in the period of an aggravation - as a part of complex therapy is possible  (with non-steroidal anti-inflammatory drugs).

Route of administration and doses:

Inside. On one reception - 2 tablets (to hold in a mouth before full dissolution - not during meal). To accept drug twice a day, in the evening and in the morning (before and after a dream). The recommended duration of administration of drug – up to 6 months.
At the expressed pain syndrome in the first 2-4 weeks of therapy administration of drug to 4 times a day, as a part of complex therapy is recommended.  At  improvement  of a state  gradually  to pass  to  reception of 2 tablets 2 times a day.

Features of use:

For 3-5 days after an initiation of treatment perhaps moderately expressed passing strengthening of a pain syndrome or local manifestations of an inflammation which is not demanding changes in the pharmacotherapy mode. In some cases at the expressed strengthening of a pain syndrome or local signs of an inflammation it is necessary to reduce temporarily a dose to 1 - 2 tablets a day.
Lactose in this connection patients are not recommended to appoint it with an inborn galactosemia, a sprue of glucose or a galactose, or at an inborn lactose intolerance is a part of drug.

Side effects:

Reactions of the increased individual sensitivity to drug components are possible.

Interaction with other medicines:

Cases of incompatibility with other medicines are not registered so far. The drug combination to non-steroidal anti-inflammatory drugs is possible.

Contraindications:

The increased individual sensitivity to drug components, age up to 18 years (in view of lack of experience of a clinical use).

Overdose:

At accidental overdose the dispepsichesky phenomena caused by the fillers which are a part of drug are possible.

Storage conditions:

In the dry, protected from light place, at a temperature not above 25 °C. To store in the place, unavailable to children. Period of validity 3 years. Not to use after expiry date.

Issue conditions:

Without recipe